Jennifer Stokes
Gerontology · Camden, SCNPI 1992281513
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 45 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,081 and has fallen 80.7% since, to $209 in 2025.
Across 211 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$453
- AstraZeneca$333
- Amgen$259
- Boehringer Ingelheim$215
- Vital Connect, Inc$196
- GSK$188
- plus $2K from 39 others
What the payments were for
- Food & beverage$3,881100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUVIVIQ$112
- TRELEGY ELLIPTA$111
How this compares
$3,881 in reported general payments places this provider in the 85th percentile of 137 gerontology providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 56 | $46,149 |
| EntrestoSacubitril/Valsartan | 20 | $24,934 |
| Repatha SureclickEvolocumab | 35 | $22,490 |
| VerquvoVericiguat | 13 | $8,230 |
| Rosuvastatin Calcium | 80 | $1,512 |
| Diltiazem 12hr ErDiltiazem Hcl | 23 | $1,242 |
| SotalolSotalol Hcl | 59 | $919 |
| Nebivolol Hcl | 18 | $898 |
| Ezetimibe | 42 | $891 |
| Metoprolol Succinate | 88 | $891 |
| Amiodarone Hcl | 38 | $720 |
| Torsemide | 36 | $675 |
| Valsartan | 29 | $673 |
| Metoprolol Tartrate | 65 | $505 |
| Losartan Potassium | 37 | $440 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $118 | $46,14956 claims |
| NovartisEntresto | $453 | $24,93420 claims |
| MerckVerquvo | $144 | $8,23013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 137 gerontology providers in South Carolina.
Other gerontology in Camden
- Ashley DiversCamden$2K
- Timothy MalinowskiGreenville$49K
- Ann ShattuckNorth Charleston$15K
- Erin SullivanColumbia$13K
- Nicole FerroniCharleston$11K
- Kathryn RarickGreenville$10K
- Ryan BakerColumbia$9K
- Rachael WillsGreenville$8K
- Karen CainGreenville$8K
- Emily KachelmeyerSummerville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.